Ethnopharmacological relevance: Drymaria cordata and Macaranga monandra are two medicinal plants traditionally used in Cameroon to treat malaria, but their scientific validation remains unclear.
Aim of the study: To validate the antiplasmodial action of extracts and fractions derived from Drymaria cordata and Macaranga monandra.
Materials and methods: Aqueous, methanolic, ethanolic, and hydroethanolic extracts of D. cordata (whole plant) and M. monandra (bark) were prepared by maceration followed by liquid-liquid partition of actives. Extracts and fractions were screened against chloroquine-sensitive (Pf3D7) and multidrug-resistant (PfDd2) strains of P. falciparum, while selectivity was determined on Vero cells. Stage-specific analysis and killing dynamics of potent fractions were profiled, complemented with UHPLC-MS analysis coupled to in silico prediction of pharmacokinetics of identified metabolites.
Results: D. cordata ethanolic extract showed moderate activity (IC50PfDd2: 18.9 μg/mL; IC50Pf3D7: 24.51 μg/mL), while all four M. monandra extracts exhibited good activity (IC50 < 8 μg/mL). The methanolic bark extract (MMBME) was highly potent and selective (IC50PfDd2: 2.46 μg/mL, SI > 203; IC50Pf3D7: 1.02 μg/mL, SI > 487). Fractionation yielded two active fractions from MMBME: F2 (IC50PfDd2: 0.60 μg/mL, IC50Pf3D7: 3.42 μg/mL) and F3 (IC50PfDd2: 0.92 μg/mL, IC50Pf3D7: 2.46 μg/mL). Fractions F2 and F3 arrested ring-stage development, lysed trophozoite-infected red blood cells, and blocked merozoite egress. UHPLC-MS analysis identified 17 metabolites in fractions F2 and F3, including fatty acyls, flavonoids, phenols, terpenes, and coumarins. Lecanoric acid was predicted as a promising antimalarial candidate.
Conclusions: Macaranga monandra bark fractions F2 and F3 are potent sources of antiplasmodial compounds targeting multiple asexual blood stages (ABS).
Keywords: Drymaria cordata; In silico prediction; In vitro efficacy; Macaranga monandra; Pharmacodynamics; Plasmodium falciparum.
Copyright © 2025 Elsevier B.V. All rights reserved.